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The American Cancer Society estimated in 2008, 
66,120 Americans would be newly diagnosed with 
non-Hodgkin’s lymphoma (NHL), contributing to ap-
proximately 19,160 deaths in 2008 [1]. Adult males and 
females are equally affected, while NHL contributes 
to about 7% of deaths in children and young adults 
below 20 years. Although a typical NHL patient is usu-
ally a white adult male, the incidence is more than 
doubled since 1970s and female patients contribute 
more for this rise. 
The World Health Organization classifies NHL 
in 2 main categories — B cell and T cell origin. B cell 
lymphomas contribute to approximately 88% of the 
NHL cases, while the rest 12% originate from T cells 
[3]. Among several lymphoma subclasses, we have 
used Burkitt’s lymphoma (Raji) and T-cell lymphoma 
(Jurkat) cell lines, both of which are fast growing, 
highly aggressive types of NHL, with poor prognosis 
and no satisfactory treatments [2]. Burkitt’s lymphoma 
accounts for about 50% of childhood NHL and exhib-
its consistently aggressive clinical behavior. Despite 
advances in treatment options, the prognosis remains 
poor due to high relapse rate and the 5-year survival 
rates are below 30% [2]. 
Rath’s work indicated that the most critical 
pathophy siology of cancer development is unre-
stricted cell proliferation and enzymatic degradation 
of the connective tissue, which can be controlled 
by nutrients essential for maintaining the connec-
tive tissue integrity. It has also shown that proteolytic 
degradation of extracellular matrix (ECM) is the key 
factor in stromal invasion of the tumors and eventual 
metastasis [4]. Matrix metalloproteinases (MMPs) 
enzymes are responsible for the tissue remo deling and 
degradation of the ECM [5, 6]. Studies have shown that 
the aggressiveness of the cancer indicated by inva-
siveness, grade and stage, is highly correlated with the 
expression of MMPs [7]. MMPs, especially MMP-2 and 
MMP-9, are identified as the most important types 
in this process. Rath and Pauling hypothesized that 
nutrients such as ascorbic acid and lysine could act 
as natural inhibitors of extracellular matrix proteolysis 
and, therefore, by stabilizing the connective tissue, 
have potential to modulate tumor growth and metas-
tasis [4]. These nutrients can mediate their antitumor 
potential through several mechanisms, including the 
inhibition of MMPs and strengthening of connective 
tissue surrounding cancer cells, thereby encapsulat-
ing the tumor [8, 9]. In hematological malignancies, 
increased levels of MMP-2 and MMP-9 are linked 
to more aggressive and advanced stages of cancer 
[3]. Positive MMP-9 expression is seen to be associ-
ated with increased prevalence of B cell lymphoma 
symptoms and worse survival [3].
The nutrient mixture (NM) is formulated to target 
the key physiological pathways in cancer progression 
and metastasis. Ascorbic acid and the amino acids 
lysine and proline are necessary for the formation 
and optimum structure of collagen fibers and there-
fore ECM integrity. Manganese and copper are also 
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essential cofactors in collagen formation. Collagen 
stability can be controlled by lysine [4] and by N-
acetyl cysteine (NAC) through its inhibitory effect 
on MMP-9 activity [11] and invasiveness of tumor 
cells [12, 13]. In addition, selenium has been shown 
to interfere with MMP expression and tumor invasion 
[14] and to induce selective apoptosis of cancer cells 
[36]. Ascorbic acid is proven to inhibit cell division and 
growth through production of hydrogen peroxide [15]. 
Green tea extract is known to be a promising agent 
in controlling angioge nesis, metastasis, and other 
aspects of cancer progression [16, 17]. Any deficiency 
of arginine can limit the production of nitric oxide, 
which predominantly acts as an inducer of apoptosis 
[18]. In addition we also found that a combination 
of ascorbic acid, lysine, and proline used with epigal-
locatechin gallate (EGCG) enhanced the anti-invasive 
activity of 20 µg/ml EGCG to that of 50µg/ml [10]. Thus 
by including NAC, arginine, selenium, manganese, and 
copper along with the combination of ascorbic acid, 
lysine, proline and EGCG, we could obtain significant 
reduction in cell invasion at a much lower concentration 
of EGCG or other components. We have reported that 
the combined effects of these individual nutrients were 
superior to the effects of each individual component 
or when they were randomly combined [10].
We have used the NM to study various soft tissue 
cancer cell lines such as fibrosarcoma, cervical can-
cer among others [8, 9]. In the current study, for the 
first time, we used hematological cancer cells, human 
Jurkat T cells and human Burkitt’s lymphoma Raji cell 
lines, because of the aggressiveness of these cancers. 
We investigated antitumor potential of NM in vitro 
on these two cell lines by measuring the cell prolifera-
tion, modulation of MMP secretion, cancer cell invasive 
potential, morphological changes and apoptosis.
MATERIALS AND METHODS
Composition of nutrient mixture (NM). Stock 
solution of the NM prepared for testing was composed 
of the following: Vitamin C (as ascorbic acid, and as Mg, 
Ca, and ascorbyl palmitate) 700 mg; L-lysine 1000 mg; 
L-proline 750 mg; L-arginine 500 mg; N-acetyl cysteine 
200 mg; standardized green tea extract 1000 mg (green 
tea extract was derived from green tea leaves obtained 
from US Pharma Lab.) The certificate of analysis indi-
cates the following characteristics: total polyphenol 
80%, catechins 60%, EGCG 35%, and caffeine 1.0%); 
selenium 30 µg; copper 2 mg; manganese 1 mg. 
Cell culture. Human Burkitt’s lymphoma Raji cells 
and human T Jurkat cells were obtained from the ATCC 
(American Type Culture Collection, Rockville, MD) and 
were grown in RPMI-1640 medium. The medium was 
supplemented with 10% fetal bovine serum, penicillin 
(100 U/ml) and streptomycin (100 mg/ml) and treated 
with the NM, dissolved in media and tested at 0, 10, 50, 
100, 500 and 1000 µg/ml in triplicates at each dose. 
Cell viability and cytotoxicity was assessed by Trypan 
blue dye exclusion test after 24 h. Viable cell count was 
expressed as a function of control. Data are shown 
as means of ± standard deviation.
Gelatinase zymography. Gelatinase zymography 
was used to determine the MMP activity in conditioned 
media. Zymography was performed in 10% Novex pre-
cast SDS-polyacrylamide gel (Invitrogen) in the pre-
sence of 0.1% gelatin under non-reduced conditions. 
Culture media (20 µl) mixed with sample buffer was 
loaded and SDS-PAGE was performed with tris glycine 
SDS buffer as described by the manufacturer (Novex). 
Samples were not boiled before electrophoresis. 
Follo wing electrophoresis, the gels were washed twice 
in 2.5% Triton X-100 for 30 min at room temperature 
to remove SDS. The gels were then incubated at 37 °C 
overnight in substrate buffer containing 50 mM Tris-
HCl and 10 mM CaCl2 at pH 8.0 and stained with 0.5% 
Coomassie Blue R250 in 50% methanol and 10% 
glacial acetic acid for 30 min and destained. Protein 
standards were run concurrently and approximate mo-
lecular weights were determined by plotting the relative 
mobilities of known proteins. Gelatinase zymograms 
were scanned using CanoScan 9950 Canon scanner 
at 1200 dpi. The intensity of the bands was evaluated 
using a pixel-based densitometer program Un-Scan-
It, version 5.1, 32 bit, by Silk Scientific Corporation (P. 
O. Box 533, Orem, UT-84059, USA), at a resolution 
of 1 Sanner Unit (1/100 of an inch for an image that 
was scanned at 100 dpi), and expressed as a percent-
age of control.
Matrigel invasion studies. Invasion studies were 
conducted using Matrigel™ (Becton-Dickinson) in-
serts in 24-well plates. Suspended in mediums, both 
Jurkat T cells and Raji leukemia cells were supple-
mented with nutrient, as specified in the design of the 
experiment and seeded on the insert in the well. Thus, 
both the medium on the insert and in the well contained 
the same supplements. The plates with the inserts 
were then incubated in a culture incubator equilibrated 
with 95% air and 5% CO2 for 24 h. After incubation, the 
media from the wells were withdrawn. The cells on the 
upper surface of the inserts were gently scrubbed. The 
outer surface of insert was washed and the media and 
washing was collected gently in the well. The media 
was spun and the cells were counted.
Morphology and apoptosis. Morphology of cul-
tured cells for 24 h in control and test concentrations 
of NM was evaluated by H&E staining and photo-
graphed by microscopy. Apoptosis was determined 
by the method described in the live green Poly Caspase 
Detection Kit at different doses of NM. Cells were 
challenged with the NM at 0, 10, 50, 100, 500 and 
1000 µg/ml concentration and incubated for 24 h. The 
culture was washed with PBS and treated with caspase 
reagent as specified in the manufacturer’s protocol 
(Molecular Probes Image-IT™ Live green Poly Cas-
pase Detection Kit 135104, Invitrogen). Cells were 
photographed under a fluorescence microscope and 
counted. Green colored cells represent viable cells, 
while yellow orange colored cells represent early apop-
tosis and red color represents late apoptosis. 
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Statistical analysis. Results were expressed 
as means ± SD for the groups. Data was analyzed 
by independent Student’s t-test.
RESULTS
Cell proliferation study. The NM exhibited dose 
response toxicity on human Burkitt’s lymphoma Raji 
cells when compared to the control: 27% at 10 µg/ml 
(p = 0.007), 42% at 50 µg/ml (p = 0.002), 58% at 100 µg/ml 
(p = 0.0003), and 88% at 500 µg/ml and 1000 µg/ml 
(p < 0.0001) of NM as shown on Fig. 1, a.
The NM was not toxic to Jurkat cells up to 
100 µg/ml but exhibited antiproliferative effect 
at 500 µg/ml NM (28%, p = 0.01) (Fig. 1, b).
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Fig. 1. Effect of NM on human Burkitt’s lymphoma Raji cells 
(a) and Jurkat T cells (b) proliferation. a, The NM shows dose 
response toxicity on Raji cells when compared to the control. 
b, The NM was non-toxic to the cells up to 100 µg/ml, but ex-
hibited anti-proliferative effect at 500 µg/ml
Gelatinase zymography study. Raji cells did not 
express any MMP by zymography. However, upon treat-
ment with PMA (100 ng/ml), zymography exhibited only 
one band corresponding to MMP-9. The NM significant-
ly decreased this expression of MMP-9 at 500 µg/ml 
and completely at 1000 µg/ml (Fig. 2, a) Densitometry 
analysis of relative activity of MMP-9 showed that the ex-
pression continued to be the same up to 100 µg/ml and 
dramatically decreased at 500 µg/ml and 1000 µg/ml, 
with R2 = 0.8094 (Fig. 2, a).
The untreated Jurkat cells did not exhibit bands 
for either MMP-2 or MMP-9. However on treatment 
with PMA (100 ng/ml) the expression of MMP-9 was 
evident. Treatment with the NM showed dose de-
pendent decrease in MMP-9 expression and virtual 
inhibition at 500 µg/ml concentration (Fig. 2, c) Densi-
tometry analysis on relative density of MMP-9 showed 
no change up to 250 µg/ml and total inhibition 
at 500 µg/ml, with R2 = 0.7436 (Fig. 2, d).
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Fig. 2. Effect of NM on MMP-9 expression by human Burkitt’s lym-
phoma Raji cells (a–b) and Jurkat T cells (c–d). a, MMP-9 expres-
sion in PMA (100 ng/ml) treated Burkitt’s lymphoma Raji cells 
is significantly decreased at 500 µg/ml and completely at 1000 
µg/ml. (Le gend: 1 — markers, 2 — control, 3 — 10 µg/ml, 
4 to 7 — NM 50 µg/ml, 100 µg/ml, 500 µg/ml, 1000 µg/ml). b, 
Densitometry analysis: effect of NM on relative activity of MMP-
9 in PMA treated Raji cells. c, Effect of NM on PMA (100 ng/ml) 
treated Jurkat T cells; NM exhibiting dose dependant decrease 
in MMP-9 expression with virtual inhibition at 500 µg/ml (Legend: 
1 — markers, 2 — control, 3 — 10 µg/ml, 4 to 7 — NM 50 µg/ml, 
100 µg/ml, 500 µg/ml, 1000 µg/ml). d, Densitometry analysis: 
effect of NM on relative activity of MMP-9
Invasion study. The NM significantly inhibited 
invasion of Raji cells through Matrigel. Compared with 
control, the NM showed 60% inhibition at 10 µg/ml con-
centration (p = 0.001), 85% at 50 µg/ml (p = 0.0003) and 
almost 100% at 100 µg/ml (p = 0.0001) (Fig. 3, a).
Significant reduction of Jurkat T cells invasion 
through Matrigel was also seen in a dose-dependent 
fashion compared to control. Invasion was conside-
rably inhibited at 500 µg/ml NM (72%; p = 0.0001), and 
100% at 1000 µg/ml NM (p < 0.0001) (Fig. 3, b).
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Fig. 3. Effect of NM on Matrigel Invasion by Burkitt’s lymphoma 
Raji cells (a) and Jurkat T cells (b). Matrigel Invasion significantly 
decreased by NM in both cell types
Morphology study and detection of apoptosis. 
Hematoxylin-eosin (H&E) staining showed no mor-
phological changes in Raji cells, up to 100 µg/ml, but 
apoptotic cells were evident at 500 and 1000 µg/ml 
(Fig. 4, a–e). The apoptotic cells showed shrinkage, 
with condensed and darkly stained nuclei and strong 
acidophilic cytoplasm. The apoptosis was further 
confirmed by using the live scan green caspase kit. 
Dose dependent apoptosis of Raji cells was evident 
with the NM challenge (Fig. 5, a–e). Slight apoptosis 
of cells was observed in cells exposed to 50 µg/ml 
and 100 µg/ml (see Fig. 5, b, c). However, the extent 
of apoptosis was reflective of the increasing doses 
of NM from 500 to 1000 µg/ml (see Fig. 5, d, e). 
Quantitative analysis of live, early and late apoptotic 
cells is shown on Fig. 5, f. Moderate apoptosis with 
51% live cells and 20% apoptotic cells are seen with 
exposure of 50 µg/ml NM. Percentage of dead cells 
increased up to 75% at 500 µg/ml and then to 81% 
at 1000 µg/ml while the percentage of live cells de-
creased with increase in dose of NM to 14% and 10%, 
respectively.
H&E staining showed slight morphological changes 
of Jurkat cells at 100 µg/ml (Fig. 6, c), and sig-
nificant apoptosis was visible at 500 and 1000 µg/ml 
(Fig. 6, d, e). Results from Live green caspase analy-
sis showed dose-dependent apoptosis in Jurkat 
T cells as well. There were a few apoptotic cells seen 
at 50 and 100 µg/ml (Fig. 7, b, c). However, the ex-
tent of apoptotic cells consistently increased from 
500 µg/ml (Fig. 7, d) to 1000 µg/ml (Fig. 7, e). Quan-
titative analysis as shown in Fig. 7, f demonstrates 
gradual increase in dead cells from 52% at 50 µg/ml 
up to 90% at 1000 µg/ml NM, significantly decreasing 
the live cells too.
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Fig. 4. Burkitt’s lymphoma Raji cells morphology photomicro-
graphs-H&E staining no morphological changes up to 100 µg/ml. 
Incremental changes were evident at 500 and 1000 µg/ml. 
a, Control; b, NM 50 µg/ml; c,NM 100 µg/ml; d, NM 5000 µg/ml; 
e, NM 1000 µg/ml.
DISCUSSION
In this study, the use of NM demonstrated signifi-
cant inhibition of both Raji and Jurkat T cells in various 
parame ters of tumor progression such as cell prolifera-
tion, MMP expression, Matrigel invasion, morphologi-
cal and apoptosis. The percentage inhibition gradually 
increased from 50 µg/ml to 1000 µg/ml NM in all cases 
and was observed to be dose dependant. MMP-9 ex-
pression was also inhi bited with virtually complete 
inhibition at 500 µg/ml in both cell types. Cell apoptosis 
increased up to 90 to 100% in both Jurkat T cells and 
Raji cells, respectively.
Decreased food intake due to anorexia-cachexia 
syndrome complicated by side effects of chemo-
therapy treatments make cancer patients vulnerable 
to deficiency of essential nutrients such as vitamin C, 
lysine, and proline leading to the formation of weak 
ECM susceptible to easy breakdown by MMPs [4]. 
Research continues to explore synthetic compounds 
to target specific MMP enzymes as cancer therapies. 
However, we think that one of the most promising 
approaches to cancer would be targeting multiple 
steps involved in cancer growth and metastasis. Thus 
by encapsulating the tumor, streng thening of connec-
tive tissue, preventing angiogenesis, and blocking 
the MMP activity we believe that cancer growth could 
be arrested. Our previous research has proven that 
control of the proteolytic degradation of ECM using 
nutrient combination provides an opportunity to ad-
dress these common mechanisms [19]. In this study 
we have used this approach to evaluate the effects 
of NM in hematological malignancies.
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Fig. 6. Human Jurkat T cells morphology photomicrographs-
H&E staining showed significant morphological changes as the 
concentration of NM increased. a, Control; b, NM 50 µg/ml; 
c, NM 100 µg/ml; d, NM 500 µg/ml; e, NM 1000 µg/ml: 
Collagen, being the main component of cellular 
basement membrane, plays a critical role in tumor inva-
sion. Our studies have indicated that the ECM integrity 
is dependant upon adequate collagen formation and 
stability [10] supported by ascorbic acid, lysine and 
proline. Ascorbic acid is essential for hydroxylation 
and for regulation of collagen synthesis at a transcrip-
tion level. Lysine, as an effective MMP blocker, helps 
to strengthen the connective tissue and prevent matrix 
invasion [4]. Lysine also prevents cancer cell migration 
by preventing MMPs binding to plasminogen-active 
sites, thereby blocking activation of plasmin by plas-
minogen [4]. However, suboptimal levels of ascorbic 
acid are possible and are already reported in cancer 
patients [20, 21] although it is cytotoxic to cancer cells 
and also possess anti-metastatic properties [22, 23]. 
Another important nutrient, proline, is a non-essential 
amino acid, yet, it is likely that the proline production 
cannot keep up with the increased demand during 
cancer. Researchers have also proven that EGCG and 
selenium induce selective apoptosis only of cancer 
Apoptosis in Raji cells
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Fig. 5. Photomicrographs of apoptosis induction in Raji Cells by NM (Live green caspase detection kit): a, Control; b, NM 50 µg/ml; 
c, NM 100 µg/ml; d, NM 500 µg/ml; e, NM 1000 µg/ml; f, Quantitative analysis of live, early and late apoptotic cells shows minimal 
apoptosis at 50 µg/ml, while profound apoptosis with increasing doses of NM
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cells [24–26] Furthermore, based on the in vivo study, 
anti-angiogenic and apoptotic effects of green tea 
in NHL are also supported [27]. Utilization of such anti-
angiogenic properties would be important considering 
that angiogenesis is postulated to have a role in clinical 
behavior and prognosis in childhood NHL [28]. Very re-
cently, clinicians from Mayo Clinic (MN, USA), reported 
significant decrease in absolute lymphocyte count and 
reduced lymphadinopathy in patients with chronic lym-
phocytic leukemia after EGCG administration in their 
phase I clinical trials [29].
The role of MMPs in hematological malignancies was 
not completely understood until Kossakowska et al. [30] 
reported the correlation between increased expression 
of MMP-9 and higher prevalence of B-cell symptoms 
in NHL. Additionally, it is documented that increased 
MMP-9 is associated with poorer prognosis of NHL 
patients [28]. Therefore it is important that MMP-9 
inhibitors should have a higher priority while exploring 
therapeutic approaches. Our current findings prove that 
NM can inhibit cell proliferation, expression of MMP-9 
and enhance the apoptotic activity of malignant cells 
at much lower doses of nutrients than that used in most 
other studies due to the synergistic effect.
Current treatment strategies for various types 
of NHL differ according to the cell types, stage, and ag-
gressiveness of the tumors. NHL has a greater tendency 
to metastasize to extra-nodal sites and about 40% 
of slow growing NHLs can quickly turn into highly. Five-
year survival rates for Burkitt’s lymphoma seem to have 
improved in the past few years, however long-term 
prognosis still remains poor and experimental treat-
ments are sporadically reported [31]. Although stem cell 
transplants are a possible option, chemotherapy and 
radiation continue to be the mainstay of treatment. Yet 
higher relapse rate, involvement of central nervous sys-
tem and treatment-associated complications dampen 
the prognosis in Burkitt’s lymphoma [2, 3]. Fatalities 
attributed to are mainly due to aggressiveness of the 
disease. However inefficacy of current therapies to halt 
the progress and its side effects further contribute 
to the mortality rate. Although researchers are focusing 
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Fig. 7. Photomicrographs of apoptosis induction in Jurkat T cells by NM (Live green caspase detection kit): a, Control; b, NM 50 µg/ml; 
c, NM 100 µg/ml; d, NM 500 µg/ml; e, NM 1000 µg/ml; f, Quantitative analysis shows increased the apoptotic cells with increasing dose 
of NM. A few apoptotic cells seen at 50 and 100 µg/ml (b, c), and extent of apoptotic cells consistently increase to 1000 µg/ml
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on developing selective medications most of them are 
in very initial phases. It could be years before patients 
have access to those, and even then the cost could 
be prohibitive. In the mean time, rising rates of NHL 
can have much higher economic impact on the society 
as children and young adults are involved.
On this background the results of our study strongly 
suggest that the NM is a potential candidate for thera-
peutic evaluation in highly aggressive. NM has shown 
the potential to inhibit MMP-9 expression, Matrigel 
invasion of Raji and Jurkat T cell lines, and increased 
selective apoptosis of malignant cells assuring safety 
for normal cells. Undeniably, additional animal and 
clinical trials are required; however development 
of such protocols could also serve as a model for other 
forms of lymphomas.
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